ESR1 and breast cancer: Non-basal-like BC can be further classified into subtypes such as luminal A, luminal B, and HER2-enriched based on the expression levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [21].